DeepMed Research

Fertin Pharma A/S

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Single-Dose Bioequivalence Study Comparing Two 2 mg Nicotine Lozenges

Phase 1

Completed

Conditions: Smoking Cessation

Interventions: Drug: Nicotine lozenge

First Posted Date: 2018-02-14

Last Posted Date: 2018-08-09

Lead Sponsor: Fertin Pharma A/S

Target Recruit Count: 42

Registration Number: NCT03432273

Locations: 🇿🇦
Bloemfontein Early Phase Clinical Unit, PAREXEL International (South Africa), Bloemfontein, South Africa

Single-Dose Bioequivalence Study Comparing Two 4 mg Nicotine Lozenges

Phase 1

Completed

Conditions: Smoking Cessation

Interventions: Drug: Nicotine lozenge

First Posted Date: 2018-02-14

Last Posted Date: 2018-08-09

Lead Sponsor: Fertin Pharma A/S

Target Recruit Count: 42

Registration Number: NCT03432312

Locations: 🇿🇦
Bloemfontein Early Phase Clinical Unit, PAREXEL International (South Africa), Bloemfontein, South Africa

Comparison of Pharmacokinetic Profiles of 3 New Nicotine Gum Formulations With a Reference Gum

Phase 1

Completed

Conditions: Smoking Cessation

Interventions: Drug: Nicotine gum

First Posted Date: 2015-02-05

Last Posted Date: 2015-02-05

Lead Sponsor: Fertin Pharma A/S

Target Recruit Count: 15

Registration Number: NCT02356913

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy